Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Assets: 2011-2021

Historic Return on Assets for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to 0.02%.

  • Neurocrine Biosciences' Return on Assets fell 4.00% to 0.02% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.02%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.03% for FY2019, which is 1.00% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Return on Assets stood at 0.02%, which was down 60.99% from 0.05% recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Return on Assets high stood at 0.14% for Q2 2020, and its period low was -0.61% during Q1 2017.
  • In the last 3 years, Neurocrine Biosciences' Return on Assets had a median value of 0.04% in 2021 and averaged 0.05%.
  • Per our database at Business Quant, Neurocrine Biosciences' Return on Assets crashed by 38bps in 2017 and then surged by 48bps in 2018.
  • Neurocrine Biosciences' Return on Assets (Quarterly) stood at -0.18% in 2017, then increased by 20bps to 0.02% in 2018, then climbed by 1bps to 0.03% in 2019, then grew by 4bps to 0.06% in 2020, then declined by 4bps to 0.02% in 2021.
  • Its last three reported values are 0.02% in Q3 2021, 0.05% for Q2 2021, and 0.05% during Q1 2021.